Docosahexaenoic acid affects insulin deficiency- and insulin resistance-induced alterations in cardiac mitochondria

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 286, Issue 3 55-3, 2004, Pages

  Ovide Bordeaux, Stéphanie ^a   Grynberg, Alain ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Mitochondrial respiration; Myocardium; Polyunsaturated fatty acid

Indexed keywords

ADENOSINE DIPHOSPHATE; CREATINE KINASE; DOCOSAHEXAENOIC ACID; FATTY ACID; FRUCTOSE; GLUTAMIC ACID; INSULIN; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PALMITOYLCARNITINE; POLYUNSATURATED FATTY ACID;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL MEMBRANE; CELL PERMEABILIZATION; CONTROLLED STUDY; DIABETES MELLITUS; DIET; DRUG EFFECT; ENZYME ACTIVITY; EXPERIMENTAL DIABETES MELLITUS; FAT INTAKE; HEART MITOCHONDRION; HEART MUSCLE; HEART MUSCLE FIBER MEMBRANE; HYPERINSULINISM; INSULIN DEFICIENCY; INSULIN RESISTANCE; KINETICS; LIPID COMPOSITION; MALE; METABOLISM; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; NONHUMAN; NUTRITIONAL DEFICIENCY; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; RAT; RAT STRAIN;

EID: 1342267450     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00303.2003     Document Type: Article

References (33)

1. Black SC, Katz S, and McNeill JH. Cardiac performance and plasma lipids of omega-3 fatty acid-treated streptozocin-induced diabetic rats. Diabetes 38: 969-974, 1989.
2. Broderick TL, Haloftis G, and Paulson DJ. L-propionylcarnitine enhancement of substrate oxidation and mitochondrial respiration in the diabetic rat heart. J Mol Cell Cardiol 28: 331-340, 1996.
3. Dagnelie P. Théories et méthodes statistiques. Gembloux, Belgium: Presses Agronomiques de Gembloux, 1975.
4. Durot I, Athias P, Oudot F, and Grynberg A. Influence of phospholipid long chain polyunsaturated fatty acid composition on neonatal rat cardiomyocyte function in physiological conditions and during glucose-free hypoxia-reoxygenation. Mol Cell Biochem 175: 253-262, 1997.
5. Eck MG, Wynn JO, Carter WJ, and Faas FH. Fatty acid desaturation in experimental diabetes mellitus. Diabetes 28: 479-485, 1979.
6. Flarsheim CE, Grupp IL, and Matlib MA. Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart. Am J Physiol Heart Circ Physiol 271: H192-H202, 1996.
7. Folch J, Lees M, and Sloane-Stanley GH. A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497-509, 1957.
8. Higashiura K, Ura N, Takada T, Agata J, Yoshida H, Miyazaki Y, and Shimamoto K. Alteration of muscle fiber composition linking to insulin resistance and hypertension in fructose-fed rats. Am J Hypertens 12: 596-602, 1999.
9. Hu Q, Ishii E, and Nakagawa Y. Differential changes in relative levels of arachidonic acid in major phospholipids from rat tissues during the progression of diabetes. J Biochem (Tokyo) 115: 405-408, 1994.
10. Hwang IS, Ho H, Hoffman BB, and Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension 10: 512-516, 1987.
11. Juaneda P and Rocquelin G. Rapid and convenient separation of phospholipids and non phosphorus lipids from rat heart using silica cartridges. Lipids 20: 40-41, 1985.
12. Kuwahara Y, Yanagishita T, Konno N, and Katagiri T. Changes in microsomal membrane phospholipids and fatty acids and in activities of membrane-bound enzyme in diabetic rat heart. Basic Res Cardiol 92: 214-222, 1997.
13. Liautaud S, Grynberg A, Mourot J, and Athias P. Fatty acids of hearts from rats fed linseed or sunflower oil and of cultured cardiomyocytes grown on their sera. Cardioscience 2: 55-61, 1991.
14. Lopaschuk GD. Abnormal mechanical function in diabetes: relationship to altered myocardial carbohydrate/lipid metabolism. Coron Artery Dis 7: 116-123, 1996.
15. Lopaschuk GD. Metabolic abnormalities in the diabetic heart. Heart Fail Rev 7: 149-159, 2002.
16. McLennan PL and Raederstorff D. Diabetes puts myocardial n-3 fatty acid status at risk in the absence of supplementation in the rat. Lipids Suppl 34: S91-S92, 1999.
17. Morrisson WR and Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluorid methanol. J Lipid Res 5: 600-608, 1964.
18. Penicaud L, Berthault MF, Morin J, Dubar M, Ktorza A, and Ferre P. Rilmenidine normalizes fructose-induced insulin resistance and hypertension in rats. J Hypertens Suppl 16: S45-S49, 1998.
19. Pepe S and McLennan PL. Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function. Circulation 105: 2303-2308, 2002.
20. Pierce GN and Dhalla NS. Heart mitochondrial function in chronic experimental diabetes in rats. Can J Cardiol 1: 48-54, 1985.
21. Rayner TE and Howe PR. Purified omega-3 fatty acids retard the development of proteinuria in salt-loaded hypertensive rats. J Hypertens 13: 771-780, 1995.
22. Rousseau D, Helies-Toussaint C, Moreau D, Raederstorff D, and Grynberg A. Dietary n-3 PUFAs affect the blood pressure rise and cardiac function modulation in a hyperinsulinemia rat model in vivo. Am J Physiol Heart Circ Physiol 285: H1294-H1302, 2003.
23. Saddik M and Lopaschuk GD. Triacylglycerol turnover in isolated working hearts of acutely diabetic rats. Can J Physiol Pharmacol 72: 1110-1119, 1994.
24. Sakamoto J, Barr RL, Kavanagh KM, and Lopaschuk GD. Contribution of malonyl-CoA decarboxylase to the high fatty acid oxidation rates seen in the diabetic heart. Am J Physiol Heart Circ Physiol 278: H1196-H1204, 2000.
25. Savabi F. Mitochondrial creatine phosphokinase deficiency in diabetic rat heart. Biochem Biophys Res Commun 154: 469-475, 1988.
26. Savabi F and Kirsch A. Alteration of the phosphocreatine energy shuttle components in diabetic rat heart. J Mol Cell Cardiol 23: 1323-1333, 1991.
27. Stark AH, Timar B, and Madar Z. Adaptation of Sprague Dawley rats to long-term feeding of high fat or high fructose diets. Eur J Nutr 39: 229-234, 2000.
28. Tanaka Y, Konno N, and Kako KJ. Mitochondrial dysfunction observed in situ in cardiomyocytes of rats in experimental diabetes. Cardiovasc Res 26: 409-414, 1992.
29. Tomita M, Mukae S, Geshi E, Umetsu K, Nakatani M, and Katagiri T. Mitochondrial respiratory impairment in streptozotocin-induced diabetic rat heart. Jpn Circ J 60: 673-682, 1996.
30. Tomlinson KC, Gardiner SM, Hebden RA, and Bennett T. Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev 44: 103-150, 1992.
31. Veksler VI, Kuznetsov AV, Sharov VG, Kapelko VI, and Saks VA. Mitochondrial respiratory parameters in cardiac tissue: a novel method of assessment by using saponin-skinned fibers. Biochim Biophys Acta 892: 191-196, 1987.
32. Veksler VI, Murat I, and Ventura-Clapier R. Creatine kinase and mechanical and mitochondrial functions in hereditary and diabetic cardiomyopathies. Can J Physiol Pharmacol 69: 852-858, 1991.
33. Voss A, Reinhart M, Sankarappa S, and Sprecher H. The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase. J Biol Chem 266: 19995-20000, 1991.